Dogwood Therapeutics Inc. (DWTX)
NASDAQ: DWTX
· Real-Time Price · USD
4.82
-0.08 (-1.63%)
At close: Sep 18, 2025, 3:59 PM
4.96
2.90%
After-hours: Sep 18, 2025, 07:35 PM EDT
Dogwood Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -24.74M | -21.98M | -12.35M | -5.73M | -4.68M | -5.07M | -5.3M | -6.24M | -7.58M | -9.8M | -12.25M | -14.71M | -16.25M | -16.86M | -15.96M | -17.95M | -16.56M | -12.94M |
Depreciation & Amortization | 34.28K | 17.02K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 188.1K | 337.05K | 476.02K | 530.52K | 584.53K | 597.24K | 619.97K | 621.2K | 637.16K | 612.45K | 582.66K | 565.03K | 532.67K | 429.96K | 322.88K | 5.62M | 7.49M | 7.45M |
Other Working Capital | -870.36K | -1.04M | -801.16K | 816.44K | -17.13K | 302.12K | 266.81K | -16.16K | -203.4K | -1.12M | -21.92K | 12.77K | 1.17M | 3.49M | -322.2K | -731.84K | -1.67M | -3.7M |
Other Non-Cash Items | 10M | 9.94M | 3.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -31.31K | -59.78K | -58.2K |
Deferred Income Tax | 190.19K | 190.04K | -503 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.42M | -1.04M | -581.27K | 1.07M | -83.9K | 363.79K | -194.45K | -456.53K | -654.63K | -1.32M | 197.38K | 175.01K | 1.58M | 3.2M | -52.19K | -436.78K | -1.57M | -3.19M |
Operating Cash Flow | -15.75M | -12.54M | -8.79M | -4.13M | -4.18M | -4.11M | -4.87M | -6.07M | -7.6M | -10.51M | -11.47M | -13.97M | -14.14M | -13.23M | -15.69M | -12.8M | -10.71M | -8.73M |
Capital Expenditures | 1.00 | -3 | -7 | -7 | -4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | 3.76M | 3.76M | 3.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 3.76M | 3.76M | 3.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | 6M | 3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 125K | 831.63K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 12.32M | 15.32M | 15.32M | -1.16M | -1.16M | -1.16M | -1.16M | n/a | 4.58M | 4.58M | 4.58M | 4.58M | n/a | n/a | -97.6K | 31.49M | 31.37M | 31.29M |
Financial Cash Flow | 22.5M | 24.08M | 16.7M | 1.38M | 2.61M | 1.16M | 1.16M | 1.07M | 4.49M | 4.49M | 4.49M | 4.58M | n/a | n/a | -97.6K | 31.49M | 31.49M | 32.12M |
Net Cash Flow | 10.38M | 15.16M | 11.53M | -2.75M | -1.57M | -2.95M | -3.71M | -5M | -3.1M | -6.02M | -6.98M | -9.4M | -14.14M | -13.23M | -15.79M | 18.69M | 20.79M | 23.39M |
Free Cash Flow | -15.75M | -12.54M | -8.79M | -4.13M | -4.18M | -4.11M | -4.87M | -6.07M | -7.6M | -10.51M | -11.47M | -13.97M | -14.14M | -13.23M | -15.69M | -12.8M | -10.71M | -8.73M |